PMID-35413689 – Epitalon Protects Against Oocyte Aging
Yue X, Liu S, Liu S, Wang A, Li H, Guo H, Zhao G, Li J. Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging (Albany NY). 2022;14(7):3191-3202.
Quick Reference
| Property | Value |
|---|---|
| PMID | 35413689 |
| DOI | 10.18632/aging.204007 |
| Year | 2022 |
| Journal | Aging (Albany NY) |
| Study Type | In vitro |
| Evidence Level | V |
| Sample | Mouse oocytes (post-ovulatory aging model) |
| Peptide(s) Studied | Epitalon |
Key Findings
- Treatment with 0.1 mM Epitalon significantly reduced oxidative damage markers (reactive oxygen species levels) in post-ovulatory aging mouse oocytes
- Epitalon improved mitochondrial membrane potential in treated oocytes, indicating preserved mitochondrial function during the aging process
- Apoptosis rates were significantly decreased in Epitalon-treated oocytes compared to untreated aging controls, suggesting a cytoprotective effect
- This study represents a fully independent, non-Khavinson validation of Epitalon's biological activity, originating from Qingdao Agricultural University in China
Study Design
Mouse oocytes were collected and subjected to in vitro post-ovulatory aging conditions. Oocytes were treated with Epitalon at 0.1 mM concentration or left untreated as controls. Outcome measures included reactive oxygen species (ROS) levels, mitochondrial membrane potential (JC-1 staining), apoptosis rates (Annexin V), and morphological assessment of oocyte quality at defined time points during the aging process.
Limitations
- In vitro oocyte model; findings may not directly translate to in vivo reproductive aging
- Single concentration tested (0.1 mM); dose-response relationship not established
- Mouse oocyte aging may not fully recapitulate human oocyte aging biology
Clinical Relevance
This study is significant as the first fully independent (non-Khavinson group) validation of Epitalon's protective biological effects. The demonstration of anti-oxidative and anti-apoptotic properties in oocytes suggests potential applications in reproductive medicine and fertility preservation, though substantial additional research including in vivo studies and human data would be required before any clinical application.
Related
#research #in-vitro #evidence-level-V